Luis Gabriel Talavera-Contreras

Publications

Citations

H-Index

2012

Active since

Affiliations

Universidad Nacional Autónoma de México(Current)

Luis Gabriel Talavera-Contreras is an author at Universidad Nacional Autónoma de México specializing in drug discovery, molecular modeling, and molecular docking.

ORCID

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesMolecular BiologyMolecular DockingMolecular ModelingMolecular Pharmacology

Publications per year

2012–2022

Publications

Potential cytotoxic and amoebicide activity of first row transition metal compounds with 2,9-bis-(2′,5′-diazahexanyl)-1,1-phenanthroline (L1)

Juan Carlos García‐Ramos, Yanis Toledano‐Magaña, Luis Gabriel Talavera-Contreras et al. · Dalton Transactions · 2012 · 23 citations

Casiopeinas® as SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitors: a combined DFT, molecular docking and ONIOM approach

Miguel Reina, Luis Gabriel Talavera-Contreras, Yeshenia Figueroa-DePaz et al. · New Journal of Chemistry · 2022 · 10 citations

Molecular Pharmacology, Combined Dft, Biochemistry +14

Rows per page

1–2 of 2